Distortion-product otoacoustic emissions and selective sensorineural loss in IDDM

Diabetes Care

Volumn 21, Issue 8, 1998, Pages 1317-1321

  Di Nardo, Walter ^a   Ghirlanda, Giovanni ^a   Paludetti, Gaetano ^a   Cercone, Stefania ^a   Saponara, Caterina ^a   Del Ninno, Massimiliano ^a   Di Girolamo, Stefano ^a   Magnani, Paolo ^a   Di Leo, Mauro A S ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; EVOKED OTOACOUSTIC EMISSION; FEMALE; HAIR CELL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NERVE CONDUCTION; PERCEPTION DEAFNESS; PERIPHERAL NEUROPATHY;

ACOUSTIC STIMULATION; ADULT; AUDITORY THRESHOLD; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; FEMALE; HEARING LOSS, SENSORINEURAL; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; NEURAL CONDUCTION; OTOACOUSTIC EMISSIONS, SPONTANEOUS; PERONEAL NERVE; REFERENCE VALUES; SURAL NERVE;

EID: 0031928637     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.8.1317     Document Type: Article

References (30)

1. Taylor I, Irwin J: Some audiological aspects of diabetes mellitus. J Laryngol Otol 92:99-113, 1978
2. Gibben K, Davis C: A hearing survey in diabetes mellitus. Clin Otolaryngol 6:345-350, 1981
3. Hamer S: Hearing in adult-onset diabetes mellitus. Otolaryngol Head Neck Surg 89:322-327, 1981
4. Verma A, Bisht M, Ahuja C: Involvement of central nervous system in diabetes mellitus, J Neurol Neurosurg Psychiatry 47:414-416, 1984
5. Khardori R, Soler N, Good D, Devlesc Howard A, Broughton D, Walbert J: Brainstem auditory and visual evoked potentials in type I (insulin-dependent) diabetic patients. Diabetologa 29:362-372, 1986
6. Virtaniemi J, Laakso M, Karja J, Nuutinen J, Karjalainem S: Auditory brainstem latencies in type I (insulin dependent) diabetic patients. Am J Otolaryngol 16:413-418, 1993
7. Simoncelli C, Ricci G, Molini E, Scionti S, Giommetti S, Pennacchi A, Bottini P: Etude des oto-émissions acqoustiques évoquées chea des patients atteints de diabète sucré. Ann Otolaryngol Chir Cervicofac 110:2255-2258, 1993
8. Di Leo MAS, Di Nardo W, Gereone S, Ciervo A, Lo Monaco M, Greco AV, Paludetti G, Ghirlanda G: Cochlear dysfunction in IDDM patients with subclinical peripheral neuropathy Diabetes Care 20:818-822, 1997
9. Kemp DT: Stimulated acoustic emissions from within the human auditory system. J Acoust Soc Am 64:1386-1391, 1978
10. Probst R, Harris FP: Transiently evoked and distortion product otoacoustic emissions. Comparison of results from normally hearing and hearing-impaired human ears. Arch Otolaryngol Head Neck Surg 119:858-860, 1993
11. Probst R: Otoacoustic emissions: an overview. Adv Otorhinolaryngol 44:1-91, 1990
12. Martin GK, Probst R, Lonsbury-Martin BL: Otoacoustic emissions in human ears: normative findings. Ear Hear 11:106-120, 1990
13. Leonard G, Smurzynski J, Jung MD, Kim DO: Evaluation of distortion product otoacoustic emissions as a basis for the objective clinical assessment of cochlear function. Adv Audiol 7:139-148, 1990
14. Probst R, Hauser R: Distortion product otoacoustic emissions in normal and hearing-impaired ears. Am J Otolaryngol 11:236-243, 1990
15. Siegel JH, Kim DO, Molnar CE: Effects of altering organ of Corti on cochlear distortion products f2-f1 and 2f1-f2. J Neurophysiol 47:303-328, 1982
16. Lonsbury-Martin BL, Martin GK: The clinical utility of distortion-product otoacoustic emissions. Ear Hear 11:144-154, 1990
17. Lonsbury-Martin BL, Martin GK, Whitehead ML: Distortion product otoacoustic emissions. In Otoacoustic Emissions: Clinical Applications. Robinette MS, Glattke TJ, Eds. New York, Thieme, 1997, p. 83-109
18. Harris FP, Probst R: Otoacoustic emissions and audiometric outcomes. In Otoacoustic Emissions: Clinical Applications. Robinette MS, Glattke TJ, Eds. New York, Thieme, 1997, p. 151-180
19. Harris FP, Probst R, Wenger R: Repeatability of transiently evoked Otoacoustic emissions in normally hearing humans. Audiology 30:135-141, 1991
20. American Diabetes Association: Report and recommendations of the San Antonio Conference on Diabetic Neuropathy (Consensus Statement). Diabetes Care 11:592-597, 1988
21. Jordao A: Consideration sur un cas du diabete. Un Med Paris 11:446, 1857
22. Jorgensen M, Buch N: Studies on inner ear function and cranial nerves in diabetics. Acta Otolaryngol 53:350-364, 1961
23. Friedmann S, Schulma R, Weiss S: Hearing and diabetic neuropathy. Arch Intern Med 135:573-576, 1975
24. Makashima K, Tanaka K: Pathological pathway in diabetics. Ann Otol Rhinol Laryngol 80:218-228, 1971
25. Kovar M: The inner ear in diabetes mellitus. ORL J Otorhinolaryngol Relat Spec 35:42-51, 1973
26. Avan P, Bonfils P, Loth D, Teyssou M, Trotoux J, Narcy P: Exploration de la cochlee par les otoemissions provoquees: interpretation physiologique des resultats. Ann Otolaryngol Chir Cervicofac 108:135-141, 1991
27. Triana R, Suits G, Garrison S, Pratzia J, Brechteisbauer P, Michaelis O, Pillsbury H: Inner ear damage secondary to diabetes mellitus I. Changes in adolescent SHR/N-cp rats. Arch Otolaryngol Head Neck Surg 117:635-640, 1991
28. Martini A, Comacchio F, Magnavita V: Auditory brainstem and middle latency evoked responses in the clinical evaluation of diabetes (Symposium). Diabet Med 8:574-577, 1991
29. Kemp DT: Otoacoustic emissions, travelling waves and cochlear mechanisms. Hear Res 22:95-104, 1986
30. Moulin A, Bera JC, Collet L: Distortion product otoacoustic emissions and sensorineural hearing loss. Audiology 33:305-326, 1994